Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2020 Filed Apr 28, 2020 21:13 UTC |
ORBIMED ADVISORS LLCDirector · 10% owner
OrbiMed Capital GP VI LLCDirector · 10% owner
|
ConversionCommon Stock | 1,875,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025990 · doc4.xml · nonDerivative · entry 2 ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner OrbiMed Capital GP VI LLC · CIK 0001682115 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,156,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. F2 · ownership.nature: This report on Form 4 is jointly filed by Advisors and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, Carl L. Gordon ("Gordon"), a member of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:06 UTC |
Chacko JacobDirector · President and CEO
|
ConversionSeries C Preferred Stock · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025981 · doc4.xml · derivative · entry 2 Chacko Jacob · CIK 0001608936 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:06 UTC |
Chacko JacobDirector · President and CEO
|
ConversionCommon Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025981 · doc4.xml · nonDerivative · entry 1 Chacko Jacob · CIK 0001608936 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series C Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionSeries B Preferred Stock · Derivative | 2,268,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 8 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 2,268,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F3 · ownership.nature: The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionSeries D Preferred Stock · Derivative | 314,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 7 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 314,815 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionSeries C Preferred Stock · Derivative | 497,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 6 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 497,809 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionSeries B Preferred Stock · Derivative | 231,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · derivative · entry 5 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 231,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionCommon Stock | 2,268,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 4 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,268,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F3 · ownership.nature: The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionCommon Stock | 314,815 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 3 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,043,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionCommon Stock | 497,809 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 2 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:11 UTC |
Topspin Fund L.P.10% owner
Topspin Biotech Fund II, L.P.10% owner
LG Management, LLC10% owner
GUTHART LEO10% owner
|
ConversionCommon Stock | 231,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025989 · doc4.xml · nonDerivative · entry 1 Topspin Fund L.P. · CIK 0001615782 · 10% owner Topspin Biotech Fund II, L.P. · CIK 0001745827 · 10% owner LG Management, LLC · CIK 0001685869 · 10% owner GUTHART LEO · CIK 0001200183 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionSeries D Preferred Stock · Derivative | 151,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 8 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 151,515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionSeries C Preferred Stock · Derivative | 416,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 7 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 416,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionSeries B Preferred Stock · Derivative | 625,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 6 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 625,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionSeries A Preferred Stock · Derivative | 3,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · derivative · entry 5 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionCommon Stock | 151,515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 4 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,768,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionCommon Stock | 416,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 3 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,616,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionCommon Stock | 625,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 2 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:42 UTC |
COLUMN GROUP II, LP10% owner
Column Group II GP, LP10% owner · General Partner
GOEDDEL DAVID V10% owner · Managing Partner
|
ConversionCommon Stock | 3,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025998 · doc4.xml · nonDerivative · entry 1 COLUMN GROUP II, LP · CIK 0001600420 · 10% owner Column Group II GP, LP · CIK 0001645333 · 10% owner · General Partner GOEDDEL DAVID V · CIK 0001182464 · 10% owner · Managing Partner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,575,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.direct: The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:07 UTC |
GORDON CARL LDirector · 10% owner
|
ConversionSeries D Preferred Stock · Derivative | 236,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025983 · doc4.xml · derivative · entry 7 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 236,111 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:07 UTC |
GORDON CARL LDirector · 10% owner
|
ConversionSeries C Preferred Stock · Derivative | 373,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025983 · doc4.xml · derivative · entry 6 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 373,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:07 UTC |
GORDON CARL LDirector · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 1,875,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025983 · doc4.xml · derivative · entry 5 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 1,875,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · derivative.exercise_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · derivative.expiration_date: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:07 UTC |
GORDON CARL LDirector · 10% owner
|
ConversionCommon Stock | 236,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 4 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,765,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:07 UTC |
GORDON CARL LDirector · 10% owner
|
ConversionCommon Stock | 373,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 3 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,529,606 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:07 UTC |
GORDON CARL LDirector · 10% owner
|
ConversionCommon Stock | 1,875,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 2 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 2,156,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:09 UTC |
SCHELLER RICHARD HDirector
|
ConversionSeries A Preferred Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025985 · doc4.xml · derivative · entry 2 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:09 UTC |
SCHELLER RICHARD HDirector
|
ConversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025985 · doc4.xml · nonDerivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:08 UTC |
Heyman Richard A.Director
|
ConversionSeries A Preferred Stock · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025984 · doc4.xml · derivative · entry 3 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 62,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 21:08 UTC |
Heyman Richard A.Director
|
ConversionCommon Stock | 62,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025984 · doc4.xml · nonDerivative · entry 2 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 227,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series A Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionSeries D Preferred Stock · Derivative | 151,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 8 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 151,515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionSeries C Preferred Stock · Derivative | 416,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 7 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 416,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionSeries B Preferred Stock · Derivative | 625,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 6 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 625,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionSeries A Preferred Stock · Derivative | 3,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · derivative · entry 5 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 3,500,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.exercise_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F1 · derivative.expiration_date: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionCommon Stock | 151,515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 4 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,768,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionCommon Stock | 416,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 3 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,616,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionCommon Stock | 625,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 2 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 28, 2020 Filed Apr 28, 2020 17:10 UTC |
Svennilson PeterDirector · 10% owner
|
ConversionCommon Stock | 3,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-025987 · doc4.xml · nonDerivative · entry 1 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,575,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date. F2 · ownership.nature: The shares are held of record by The Column Group II, LP ("TCG II LP"). The Column Group II GP, LP ("TCG II GP") is the general partner of TCG II LP. The Reporting Person is a Managing Partner of TCG II GP and may be deemed to share voting and investment power with respect to the shares reported herein. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 21:13 UTC |
ORBIMED ADVISORS LLCDirector · 10% owner
OrbiMed Capital GP VI LLCDirector · 10% owner
|
PurchaseCommon Stock | 281,250 | $16.00 | $4,500,000.00 |
DisclosureSEC source: 0001209191-20-025990 · doc4.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner OrbiMed Capital GP VI LLC · CIK 0001682115 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 281,250 F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. F2 · ownership.nature: This report on Form 4 is jointly filed by Advisors and GP VI. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, Carl L. Gordon ("Gordon"), a member of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 21:07 UTC |
GORDON CARL LDirector · 10% owner
|
PurchaseCommon Stock | 281,250 | $16.00 | $4,500,000.00 |
DisclosureSEC source: 0001209191-20-025983 · doc4.xml · nonDerivative · entry 1 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 281,250 F1 · ownership.nature: The shares are held of record by by OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Capital GP VI LLC ("GP VI") is the general partner of OPI VI and OrbiMed Advisors LLC ("Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and Advisors may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial ownership over such securities. Advisors exercises voting and investment power through a management committee comprised of the Reporting Person, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OPI VI. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:37 UTC |
Chacko JacobDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 437,500 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025801 · doc4.xml · derivative · entry 1 Chacko Jacob · CIK 0001608936 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,500 Underlying: Common Stock · 437,500 shares Expires 2030-04-22 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:42 UTC |
Piscitelli DominicChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 86,250 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025808 · doc4.xml · derivative · entry 1 Piscitelli Dominic · CIK 0001695028 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,250 Underlying: Common Stock · 86,250 shares Expires 2030-04-22 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:38 UTC |
GORDON CARL LDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 16,625 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025803 · doc4.xml · derivative · entry 1 GORDON CARL L · CIK 0001282930 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Underlying: Common Stock · 16,625 shares Expires 2030-04-22 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) April 23, 2021 or (ii) the business day immediately preceding the Issuer's next annual stockholders' meeting. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:40 UTC |
SCHELLER RICHARD HDirector
|
GrantStock Option (right to buy) · Derivative | 33,250 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025805 · doc4.xml · derivative · entry 1 SCHELLER RICHARD H · CIK 0001214133 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,250 Underlying: Common Stock · 33,250 shares Expires 2030-04-22 F1 · derivative.exercise_date: One thirty-sixth (1/36) of the shares subject to the option shall vest May 23, 2020, and an additional thirty-sixth (1/36) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:43 UTC |
Multani Pratik SChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 147,500 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025810 · doc4.xml · derivative · entry 1 Multani Pratik S · CIK 0001586894 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,500 Underlying: Common Stock · 147,500 shares Expires 2030-04-22 F1 · derivative.exercise_date: 25% of the shares subject to the option shall vest on April 23, 2021, and 1/48 of the shares subject to the option shall vest each month thereafter. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 16:41 UTC |
Dier MardiDirector
|
GrantStock Option (right to buy) · Derivative | 33,250 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025807 · doc4.xml · derivative · entry 1 Dier Mardi · CIK 0001574591 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,250 Underlying: Common Stock · 33,250 shares Expires 2030-04-22 F1 · derivative.exercise_date: One thirty-sixth (1/36) of the shares subject to the option shall vest May 23, 2020, and an additional thirty-sixth (1/36) of the shares subject to the option shall vest each month thereafter. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 20:39 UTC |
Heyman Richard A.Director
|
GrantStock Option (right to buy) · Derivative | 16,625 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025804 · doc4.xml · derivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Underlying: Common Stock · 16,625 shares Expires 2030-04-22 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) April 23, 2021 or (ii) the business day immediately preceding the Issuer's next annual stockholders' meeting. Read SEC document |
| April 23, 2020 Filed Apr 27, 2020 16:41 UTC |
Svennilson PeterDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 16,625 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-025806 · doc4.xml · derivative · entry 1 Svennilson Peter · CIK 0001606074 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Underlying: Common Stock · 16,625 shares Expires 2030-04-22 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) April 23, 2021 or (ii) the business day immediately preceding the Issuer's next annual stockholders' meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.